Chennai’s Attox launches rapid antibiotic tester Bactolizer
Chennai-based startup Attox has unveiled the Bactolizer, a tabletop device designed to identify the most effective antibiotic and dose for a bacterial infection in 30 minutes to two hours. The company suggests the test could shorten the typical wait time for lab results, potentially fitting within a single clinical shift.
YourStory reported on the device this week, noting its potential to address challenges in India’s public hospitals, where over-prescription of broad-spectrum antibiotics has contributed to antimicrobial resistance. While Attox has not shared details on pricing or early adopters, the emphasis on speed and portability implies a focus on point-of-care use rather than traditional lab settings.
The announcement comes as India’s health-tech sector sees increased investment from specialized funds. W Health Ventures’ $73 million Fund II, covered by StartupReader in September, signaled plans to build startups internally to fill clinical gaps—Attox’s device appears to align with that mission, though widespread adoption may depend on coverage by insurers or government programs.
Sources: yourstory.com
“Attox’s rapid antibiotic sensitivity test could help reduce hospital stays and slow antimicrobial resistance in India’s healthcare system.”
Read the original reporting
The outlets below did the original reporting.
Related briefs
- Indian CTOs rethink AI stack ownership amid agent boom
- Allara raises $30M to scale AI-augmented women’s health care
- DailyObjects eyes ₹400 Cr revenue after smartphone accessory pivot
- AgniKul, GalaxEye founders share spacetech failure lessons
- Quick commerce shifts from convenience to brand playbook in India
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.